Showing results (11-20 of 265) with videos related to

Sort By:
Pageof 27
Clinical Science (London, England : 1979)|February 1, 1997
Comparison of forearm vasodilatation to substance P and acetylcholine: contribution of nitric oxideD E Newby, N A Boon, D J Webb
The Journal of the Royal College of Physicians of Edinburgh|July 8, 2014
Molecular imaging of the atherosclerotic plaque using positron emission tomographyI S Toor, M R Dweck, D E Newby
Investigative Ophthalmology & Visual Science|July 7, 1999
Peripheral endothelial dysfunction in normal pressure glaucomaE Henry, D E Newby, D J Webb, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|December 3, 2014
Association between salivary cotinine and cardiovascular biomarkers among nonsmokers and current smokers: cross-sectional study of 10,081 participantsL Lu, D F Mackay, D E Newby, et al.
Cardiovascular Research|October 31, 2001
Short-term effects of transdermal nicotine on acute tissue plasminogen activator release in vivo in manM P Pellegrini, D E Newby, S Maxwell, et al.
IEEE Transactions on Radiation and Plasma Medical Sciences|July 14, 2018
Multimodality quantitative assessments of myocardial perfusion using dynamic contrast enhanced magnetic resonance and 15O-labelled water positron emission tomography imagingG Papanastasiou, M C Williams, M R Dweck, et al.
Heart (British Cardiac Society)|October 1, 1996
Caffeine restriction has no role in the management of patients with symptomatic idiopathic ventricular premature beatsD E Newby, J M Neilson, D R Jarvie, et al.
QJM : Monthly Journal of the Association of Physicians|August 26, 1998
A 'same day' direct-access chest pain clinic: improved management and reduced hospitalizationD E Newby, K A Fox, L L Flint, et al.
Heart (British Cardiac Society)|May 3, 2005
Phosphodiesterase type 5 inhibition does not reverse endothelial dysfunction in patients with coronary heart diseaseS D Robinson, C A Ludlam, N A Boon, et al.
Journal of Thrombosis and Haemostasis : JTH|July 14, 2006
Tissue plasminogen activator genetic polymorphisms do not influence tissue plasminogen activator release in patients with coronary heart diseaseS D Robinson, C A Ludlam, N A Boon, et al.
Pageof 27